3d48: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px <!-- The line below this paragraph, containing "STRUCTURE_3d48", creates the "Structure Box" on the page. You may change the PDB parameter (which sets the PD...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:3d48.jpg|left|200px]]
{{Seed}}
[[Image:3d48.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_3d48|  PDB=3d48  |  SCENE=  }}  
{{STRUCTURE_3d48|  PDB=3d48  |  SCENE=  }}  


'''Crystal structure of a prolactin receptor antagonist bound to the extracellular domain of the prolactin receptor'''
===Crystal structure of a prolactin receptor antagonist bound to the extracellular domain of the prolactin receptor===




==Overview==
<!--  
The crystal structure of the complex between a N-terminally truncated G129R human prolactin (PRL) variant and the extracellular domain (ECD) of the human prolactin receptor (PRLR) was determined at 2.5 A resolution by X-ray crystallography. This structure represents the first experimental structure reported for a PRL variant bound to its cognate receptor. The binding of PRL variants to PRLR-ECD was furthermore characterized by the solution state techniques, hydrogen exchange mass spectrometry (HX-MS) and nuclear magnetic resonance (NMR) spectroscopy. Compared to the binding interface derived from mutagenesis studies, the structural data imply that the definition of PRL binding site 1 (BS1) should be extended to include residues situated in the N-terminal part of loop 1 and in the C-terminus. Comparison of the structure of the receptor bound PRL variant with the structure reported for the unbound form of a similar analogue (Jomain et al. J. Biol. Chem. 282 (45), 33118-33131 (2007)) demonstrates that receptor induced changes in the back-bone of the four helix bundle are subtle, whereas large scale rearrangements and structuring occur in the flexible N-terminal part of loop 1. HX-MS data imply that the dynamics of the four-helix bundle in solution generally become stabilized upon receptor interaction at BS1.
The line below this paragraph, {{ABSTRACT_PUBMED_18467331}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 18467331 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_18467331}}


==About this Structure==
==About this Structure==
Line 35: Line 39:
[[Category: Secreted]]
[[Category: Secreted]]
[[Category: Transmembrane]]
[[Category: Transmembrane]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jun  4 09:56:42 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 15:04:17 2008''